+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
FEMALE
ID05366699

Study of LYMPHA Procedure to Prevent Lymphedema in Women Undergoing Axillary Lymphadenectomy for Breast Cancer

Led by Stanford University · Updated on 2026-08-12

100

Participants Needed

1

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Lymphedema is a long-lasting and worsening condition caused by problems with the lymphatic system, often happening after breast cancer treatment. This trial aims to see if a low-risk lymphatic reconstruction technique done during axillary lymph node removal can lower the chance of developing lymphedema. It also examines if this surgery improves measurable lymphedema outcomes and patient quality of life. Participants will be randomly assigned to one of three groups one receiving axillary lymphadenectomy alone, another having axillary lymphadenectomy with soft tissue reinforcement, and the last group undergoing axillary lymphadenectomy with immediate lymphatic reconstruction LYMPHA using reverse mapping and the SPY System. These procedures are compared to assess their effects on lymphedema prevention. During the study, participants will be monitored for up to two years to measure lymphatic flow patterns, limb volume, skin thickness, bioimpedance spectroscopy, and quality of life specific to limb lymphedema using the LYMQOL tool. These assessments help track the impact of the procedures on lymphedema development and patient well-being over time.

CONDITIONS

Brief Title

LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy

Research Team

D

Dung Nguyen, MD, PharmD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here